|
Fred Krieger has spent most his career directing various financial aspects of leading pharmaceutical companies. Prior to joining Iroko Pharmaceuticals, Mr. Krieger spent six years as Vice President, Financial Control, Planning and Reporting, at GlaxoSmithKline Pharmaceuticals Research & Development. There he directed the R&D accounting, consolidation, and reporting process, and was responsible for the overall budgeting and three-year planning process for R&D.
Mr. Krieger formerly held positions of increasing responsibility at SmithKline Beecham Pharmaceuticals, including positions in Philadelphia and London. For a number of years Mr. Krieger directly supported the Chief Executive Officer. He holds BBA and MBA degrees and is a Certified Public Accountant. | 